494 related articles for article (PubMed ID: 25013816)
1. MicroRNAs expression profiles in cardiovascular diseases.
Bronze-da-Rocha E
Biomed Res Int; 2014; 2014():985408. PubMed ID: 25013816
[TBL] [Abstract][Full Text] [Related]
2. [MicroRNA--a new diagnostic tool in coronary artery disease and myocardial infarction].
Fic P; Kowalczuk K; Grabarska A; Stepulak A
Postepy Hig Med Dosw (Online); 2014 Apr; 68():410-8. PubMed ID: 24864093
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs as biomarkers for myocardial infarction.
Salic K; De Windt LJ
Curr Atheroscler Rep; 2012 Jun; 14(3):193-200. PubMed ID: 22392328
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Biomarkers and Cardiovascular Disease: Circulating MicroRNAs.
de Gonzalo-Calvo D; Iglesias-Gutiérrez E; Llorente-Cortés V
Rev Esp Cardiol (Engl Ed); 2017 Sep; 70(9):763-769. PubMed ID: 28623159
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs as Potential Biomarkers in Coronary Artery Disease.
Bergami M; Fabin N; Cenko E; Bugiardini R; Manfrini O
Curr Top Med Chem; 2023; 23(6):454-469. PubMed ID: 36545717
[TBL] [Abstract][Full Text] [Related]
6. A subset of circulating microRNAs is expressed differently in patients with myocardial infarction.
Liang J; Bai S; Su L; Li C; Wu J; Xia Z; Xu D
Mol Med Rep; 2015 Jul; 12(1):243-7. PubMed ID: 25738515
[TBL] [Abstract][Full Text] [Related]
7. Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction.
Gidlöf O; Smith JG; Miyazu K; Gilje P; Spencer A; Blomquist S; Erlinge D
BMC Cardiovasc Disord; 2013 Feb; 13():12. PubMed ID: 23448306
[TBL] [Abstract][Full Text] [Related]
8. Identifying differential miR and gene consensus patterns in peripheral blood of patients with cardiovascular diseases from literature data.
Šatrauskienė A; Navickas R; Laucevičius A; Huber HJ
BMC Cardiovasc Disord; 2017 Jun; 17(1):173. PubMed ID: 28666417
[TBL] [Abstract][Full Text] [Related]
9. Opportunities for microRNAs in the Crowded Field of Cardiovascular Biomarkers.
Halushka PV; Goodwin AJ; Halushka MK
Annu Rev Pathol; 2019 Jan; 14():211-238. PubMed ID: 30332561
[TBL] [Abstract][Full Text] [Related]
10. The Role of MicroRNAs in Myocardial Infarction: From Molecular Mechanism to Clinical Application.
Sun T; Dong YH; Du W; Shi CY; Wang K; Tariq MA; Wang JX; Li PF
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28362341
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?
Fichtlscherer S; Zeiher AM; Dimmeler S
Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2383-90. PubMed ID: 22011751
[TBL] [Abstract][Full Text] [Related]
12. Next generation MicroRNA sequencing to identify coronary artery disease patients at risk of recurrent myocardial infarction.
Kanuri SH; Ipe J; Kassab K; Gao H; Liu Y; Skaar TC; Kreutz RP
Atherosclerosis; 2018 Nov; 278():232-239. PubMed ID: 30336307
[TBL] [Abstract][Full Text] [Related]
13. Exercise training reveals micro-RNAs associated with improved cardiac function and electrophysiology in rats with heart failure after myocardial infarction.
Stølen TO; Høydal MA; Ahmed MS; Jørgensen K; Garten K; Hortigon-Vinagre MP; Zamora V; Scrimgeour NR; Berre AMO; Nes BM; Skogvoll E; Johnsen AB; Moreira JBN; McMullen JR; Attramadal H; Smith GL; Ellingsen Ø; Wisløff U
J Mol Cell Cardiol; 2020 Nov; 148():106-119. PubMed ID: 32918915
[TBL] [Abstract][Full Text] [Related]
14. Circulating microRNAs (miR-423-5p, miR-208a and miR-1) in acute myocardial infarction and stable coronary heart disease.
Nabiałek E; Wańha W; Kula D; Jadczyk T; Krajewska M; Kowalówka A; Dworowy S; Hrycek E; Włudarczyk W; Parma Z; Michalewska-Włudarczyk A; Pawłowski T; Ochała B; Jarząb B; Tendera M; Wojakowski W
Minerva Cardioangiol; 2013 Dec; 61(6):627-37. PubMed ID: 24253456
[TBL] [Abstract][Full Text] [Related]
15. Role of microRNAs in cardiac hypertrophy and heart failure.
Wang N; Zhou Z; Liao X; Zhang T
IUBMB Life; 2009 Jun; 61(6):566-71. PubMed ID: 19472179
[TBL] [Abstract][Full Text] [Related]
16. MiR-23a Regulates the Vasculogenesis of Coronary Artery Disease by Targeting Epidermal Growth Factor Receptor.
Wang S; He W; Wang C
Cardiovasc Ther; 2016 Aug; 34(4):199-208. PubMed ID: 27085964
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs as circulating biomarkers in acute coronary syndromes: A review.
Ahlin F; Arfvidsson J; Vargas KG; Stojkovic S; Huber K; Wojta J
Vascul Pharmacol; 2016 Jun; 81():15-21. PubMed ID: 27084396
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs: Novel Players in Aortic Aneurysm.
Fu XM; Zhou YZ; Cheng Z; Liao XB; Zhou XM
Biomed Res Int; 2015; 2015():831641. PubMed ID: 26221607
[TBL] [Abstract][Full Text] [Related]
19. miRNAs emerge as circulating biomarkers of post-myocardial infarction heart failure.
Cruz MS; da Silva AMG; de Souza KSC; Luchessi AD; Silbiger VN
Heart Fail Rev; 2020 Mar; 25(2):321-329. PubMed ID: 31254148
[TBL] [Abstract][Full Text] [Related]
20. Systematic analysis of lncRNA and microRNA dynamic features reveals diagnostic and prognostic biomarkers of myocardial infarction.
Shi H; Sun H; Li J; Bai Z; Wu J; Li X; Lv Y; Zhang G
Aging (Albany NY); 2020 Jan; 12(1):945-964. PubMed ID: 31927529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
